Skip to main content

Table 2 Pretreatment characteristics

From: Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy

  

No ENI (109)

ENI (103)

p

  

Frequencies1 (%)

 

Plan type

Tomotherapy

47 (43%)

47 (46%)

0.081

 

IMRT

22 (20%)

28 (28%)

 
 

Arc

40 (37%)

28 (27%)

 

ADT

 

44 (40%)

98 (95%)

<0.001

  

Means2 (±SD)

 

Age at start of RT

 

67.5 (±8.5)

67.1 (±7.8)

0.631

Prostate volume (cc)

 

53.4 (±29.8)

46.2 (±24.3)

0.055

Rectum volume (cc)

 

92.9 (±53.5)

98.0 (±47.5)

0.467

Bladder volume (cc)

 

227.7 (±147.4)

206.2 (±164.2)

0.317

  1. 1Person χ2 test. 2Independent samples T-test. Bolded text indicates a statistically significant difference.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us